Start Date
May 6, 2021
Primary Completion Date
April 19, 2022
Study Completion Date
January 28, 2025
Azacitidine
Participants will receive subcutaneous (SC) or intravenous (IV) injection of Azacitidine 75 mg/m\^2.
Cusatuzumab
Participants will receive SC or IV injection of Cusatuzumab 20 mg/kg.
Hopitaux Universitaires de Geneve, Geneva
St Vincents Hospital Sydney, Darlinghurst
Westmead Hospital, Westmead
Wollongong Hospital, Wollongong
INSELSPITAL, Universitätsspital Bern, Bern
St Vincents Hospital Melbourne, Fitzroy
Royal Perth Hospital, Perth
Hosp. Univ. Son Espases, Palma
Aou San Luigi Gonzaga, Orbassano
King Faisal Specialist Hospital & Research Center, Riyadh
Hôpital de La Conception, Marseille
King Fahad Specialist hospital, Dammam
Istituto Clinico Humanitas, Rozzano
King Abdulaziz Medical City, Jeddah
Hosp. Univ. Infanta Leonor, Madrid
Centro Integral Oncológico Clara Campal, Madrid
Università del Piemonte Orientale - Ospedale Maggiore della Carità di Novara, Novara
Medizinische Hochschule Hannover, Hanover
Koc Universitesi Hastanesi, Istanbul
Ege Universitesi Tip Fakultesi, Izmir
Dokuz Eylul Universitesi Tip Fakultesi, Izmir
CHRU Tours Hôpital Bretonneau, Tours
Hosp. Clinico Univ. de Salamanca, Salamanca
Policlinico Sant'Orsola Malpighi, Bologna
Hosp. Virgen Del Rocio, Seville
Azienda Ospedaliero Universitaria di Ferrara, Cona
CHU d'Angers, Angers
CHU de Nancy_ Hôpital Brabois, Vandœuvre-lès-Nancy
Ondokuz Mayis Universitesi Tip Fakultesi, Samsun
Hopital Saint Vincent de Paul, Lille
Hopital Saint-Louis, Paris
Hopital Cochin APHP, Paris
Universitätsklinik Freiburg, Freiburg im Breisgau
Klinikum rechts der Isar an der Technischen Universität München, München
CHU de Limoges, Hopital Dupuytren, Limoges
Universitaetsklinikum Ulm, Ulm
Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli' Reggio Calabria, Reggio Calabria
Saint Petersburg City Hospital #15, Saint Petersburg
S.P. Botkin Moscow City Clinical Hospital, Moscow
Oncology Dispensary of Komi Republic, Syktyvkar
Clinical Research Institute of Hematology and Transfusiology, Saint Petersburg
St.-Petersburg City Clinical Hospital nr 31, Saint Petersburg
Ryazan Regional Clinical Hospital, Ryazan
Nizhniy Novgorod Region Clinical Hospital, Nizhny Novgorod
Emergency Hospital of Dzerzhinsk, Dzerzhinsk
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo
Peter MacCallum Cancer Institute, Melbourne
UniversitaetsSpital Zuerich, Zurich
Hospital Erasto Gaertner- Liga Paranaense de Combate ao Câncer, Curitiba
Cepon - Centro De Pesquisas Oncologicas, Florianópolis
Liga Norte Riograndense Contra O Cancer, Natal
Hospital de Clínicas de Porto Alegre, Porto Alegre
Instituto do cancer -COR -Hospital Mae de Deus, Porto Alegre
Oncoclínicas, Rio de Janeiro
Hospital de Base de São José do Rio Preto, São José do Rio Preto
Hospital Paulistano, São Paulo
CHU de Nice Hopital de l Archet, Nice
Dr.Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara
Universitatsklinikum Carl Gustav Carcus Dresden, Dresden
Universitatsklinikum Leipzig, Leipzig
Fondazione Policlinico Tor Vergata, Roma
Policlinico Umberto I, Roma
Hosp. Univ. Germans Trias I Pujol, Badalona
Hosp. Univ. Vall D Hebron, Barcelona
Hosp. de La Santa Creu I Sant Pau, Barcelona
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona
Gulhane Egitim ve Arastirma Hastanesi, Ankara
Ankara Universitesi Tip Fakultesi, Ankara
St James Hospital, Leeds
University College London Hospitals, London
Kings College Hospital, London
Royal Victoria Infirmary, Newcastle Upun Tyne
Churchill Hospital, Oxford
Collaborators (1)
argenx
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY